Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 19/20 | 0.70 |
| ▸ | MAPK13 | O15264 | 13/20 | 0.62 |
| ▸ | MAPK12 | P53778 | 13/20 | 0.62 |
| ▸ | MAPK11 | Q15759 | 13/20 | 0.62 |
| ▸ | MAPK9 | P45984 | 5/20 | 0.62 |
| ▸ | RAF1 | P04049 | 3/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7748832 | 1.00 | MAPK14 (0.70) | MAPK14MAPK13MAPK12MAPK11MAPK9 | |
| SCHEMBL7743195 | 0.93 | MAPK14 (0.71) | MAPK14MAPK13MAPK12MAPK11MAPK9 | |
| SCHEMBL7743194 | 0.93 | MAPK14 (0.71) | MAPK14MAPK13MAPK12MAPK11MAPK9 | |
| SCHEMBL8002384 | 0.84 | MAPK14 (0.79) | MAPK14MAPK13MAPK12MAPK11MAPK9 | |
| SCHEMBL7747157 | 0.83 | MAPK14 (0.58) | MAPK14MAPK13MAPK12MAPK11MAPK9 | |
| SCHEMBL7747154 | 0.83 | MAPK14 (0.58) | MAPK14MAPK13MAPK12MAPK11MAPK9 | |
| SCHEMBL7747250 | 0.83 | MAPK14 (0.76) | MAPK14MAPK13MAPK12MAPK11MAPK9 | |
| SCHEMBL7743202 | 0.82 | MAPK14 (0.60) | MAPK14MAPK13MAPK12MAPK11MAPK9 | |
| SCHEMBL5786346 | 0.79 | MAPK14 (0.59) | MAPK14MAPK13MAPK12MAPK11MAPK9 | |
| SCHEMBL5786349 | 0.79 | MAPK14 (0.59) | MAPK14MAPK13MAPK12MAPK11MAPK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001022965-A1 | SUBSTITUTED IMIDAZOLES HAVING CYTOKINE INHIBITORY ACTIVITY | MERCK & CO., INC. (US) | 2001-04-05 | — | — | WO | disclosed |